SUPPLEMENTARY INFORMATION Clinical definitions
Pre-eclampsia was defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg with new-onset proteinuria (≥0.3g/24h) after 20 weeks of gestation 1 . Pre-eclampsia was defined early-onset when diagnosed before 34+0 weeks of gestation, and severe in the presence of systolic blood pressure ≥160 mmHg, diastolic blood pressure ≥110 mmHg, proteinuria ≥5 g/24h or clinically severe symptoms of preeclampsia, including clonus or respiratory distress. Birth weights below −2.0 SD units (birth weight relative to sex and length of gestation) according to Finnish standards 2 were classified as SGA. Placental insufficiency was defined as uterine artery resistance index or pulsatility index >+2 SD units. In the FINNPEC cohort, the diagnoses were determined based on medical records and verified independently by a research nurse and a study physician.
Sample collection and DNA extraction
A venous blood sample of 36 ml was drawn from each study participant, and genomic DNA was extracted from whole blood using the NucleoSpin Blood XL DNA extraction kit (Macherey-Nagel
GmbH & Co.) or Chemagic Magnetic Separation Module I -machine (Chemagen). The extracted DNA was stored at -20°C.
Exome sequencing
Exome sequencing was performed at the Science for Life Laboratory, Stockholm, Sweden. DNA libraries were prepared from 3 µg of input material sheared to 300 bp using a Covaris S2 instrument Early-onset, severe pre-eclampsia PE 3
Severe pre-eclampsia, proteinuria >6g/24h PE 4
Severe pre-eclampsia, proteinuria >6g/24h PE 5
Severe pre-eclampsia, previous miscarriage(s) PE 6
Severe pre-eclampsia, proteinuria >3g/24h PE 7
Severe pre-eclampsia PE 8
Severe pre-eclampsia PE 9
Severe, recurrent pre-eclampsia PE 10
Familial pre-eclampsia
